fig2
![Perspective article: determinants and assessment of cardiovascular risk in steatotic liver disease owing to metabolic dysfunction-addressing the challenge](https://image.oaes.cc/c1bffa0a-f7bf-4a13-ab48-f1d03ca6e933/mtod4034.fig.2.jpg)
Figure 2. Proposed Algorithm for Cardiovascular Risk Assessments in MASLD. FIB-4: fibrosis-4; NFS: NAFLD fibrosis score; MASLD: Metabolic dysfunction-associated steatotic liver disease; TE: transient elastography; MRE: magnetic resonance elastography; CVD: cardiovascular disease.